Status:
RECRUITING
Stockholm Myocardial Infarction with Nonobstructive Coronaries Study 3
Lead Sponsor:
Karolinska Institutet
Collaborating Sponsors:
Region Stockholm
Conditions:
Myocardial Infarction with Nonobstructive Coronary Arteries
Eligibility:
All Genders
35-79 years
Phase:
NA
Brief Summary
The present pilot study will investigate the prevalence of CMD in an unselected cohort of patients with the working diagnosis MINOCA and to study if the diagnostic yield can be improved by adding aden...
Eligibility Criteria
Inclusion
- a suspected diagnosis of MINOCA or takotsubo syndrome with coronary angiography without diameter stenosis ≥50%
- age 35-80 years
- reading and writing proficiency in Swedish
Exclusion
- Claustrofobia
- Arrythmia and/or pacemaker (atrial fibrillation and AV-block I- III)
- Asthma or severe chronic obstructive lung disease
- eGFR \< 30 ml/min
- spontaneous coronary artery dissection
- acute pulmonary embolism
- acute myocardial infarction type 2
- cardiomyopathy other than takotsubo syndrome
- a previous myocardial infarction due to CAD
Key Trial Info
Start Date :
November 1 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 30 2026
Estimated Enrollment :
85 Patients enrolled
Trial Details
Trial ID
NCT05426408
Start Date
November 1 2022
End Date
June 30 2026
Last Update
March 10 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Per Tornvall
Stockholm, Sweden, 11551